Instil Bio (TIL) Treasury Shares (2020)

Instil Bio (TIL) posted quarterly Treasury Shares of $70.2 million for Q4 2020, up 17.74% quarter-over-quarter from $59.6 million in Q3 2020.

Instil Bio (TIL) Treasury Shares (2020) Analysis & Trends

Instil Bio's Treasury Shares history runs 1 years deep, the most recent figure standing at $70.2 million for Q4 2020.

In Q4 2020, Treasury Shares changed N/A year-over-year to $70.2 million; the TTM figure through Dec 2020 stood at $70.2 million (changed N/A YoY), while the FY2020 annual figure was $70.2 million, changed N/A from the prior year.
Treasury Shares for Q4 2020 stood at $70.2 million, up from $59.6 million in the prior quarter.
The five-year high for Treasury Shares was $70.2 million in Q4 2020, with the low at $15.0 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	138.83 Bn	130.98 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.79 Bn	77.79 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.95 Bn	59.77 Bn	1.37 Bn	-
4	Moderna	58.59 Bn	53.46 Bn	52.00 Mn	-
5	BeOne Medicines	41.93 Bn	36.83 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.52 Bn	28.21 Bn	992.69 Mn	-
7	BioNTech SE	27.98 Bn	9.58 Bn	668.28 Mn	8.96 Mn
8	Insmed	27.42 Bn	26.26 Bn	358.27 Mn	-
9	Royalty Pharma	27.33 Bn	26.49 Bn	-	2.72 Mn
10	Instil Bio	51.34 Mn	51.34 Mn	-	-

Download Data